Intensive Care Unit: Clinical Trials

5 trials for Intensive Care Unit, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Intensive Care Unit: new trials by email Literature Review of Intensive Care Unit trials Research Report on Intensive Care Unit

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
propranolol, normal saline IV - Traumatic Brain Injury (TBI) Patients, Intracranial Pressure
Phase 3Not yet recruitingTanta University602025-09-202025-03-11
Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
Tocilizumab Injection, Deferoxamine - COVID19, Intensive Care Unit
Phase 3UnknownAbderrahmane Mami Hospital2602020-09-042020-08-27
Evaluation of the Analgesia by Serratus Plane Block During Pleural Drainage in Intensive Care Unit.
lidocaine treatment, serratus plane block treatment - Analgesia, Lidocaine
Phase 3RecruitingCentre Hospitalier Universitaire, Amiens702019-06-042026-05-13
Lessening Organ Dysfunction With VITamin C
Vitamin C, Control - Sepsis, Vitamin C
Phase 3CompletedUniversité de Sherbrooke8722018-11-082022-04-04
Vitamin D Supplementation in Intensive Care Unit Patients
Vitamin D supplementation - Dietary Supplements, Intensive Care Unit
Phase 3CompletedAssociation Tunisienne d'Etude & de Recherche sur l'Athérosclérose3402016-01-202021-06-18

Narrower conditions

COVID-19 (2)  ·  Agnosia (1)  ·  Brain Injuries, Traumatic (1)  ·  Coronavirus Infections (1)  ·  Critical Illness (1)  ·  Sepsis (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Coronaviridae Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nervous System Diseases (2)  ·  Nidovirales Infections (2)  ·  Pathologic Processes (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Avitaminosis (1)  ·  Brain Diseases (1)

Interventions

Ascorbic Acid (1)  ·  Control Groups (1)  ·  Deferoxamine (1)  ·  Propranolol (1)  ·  tocilizumab (1)

Sponsors

Abderrahmane Mami Hospital (1)  ·  Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Tanta University (1)  ·  Université de Sherbrooke (1)

Countries

Canada (1)  ·  Egypt (1)  ·  France (1)  ·  Tunisia (1)

Top investigators

Huda Elkallaf, Resident (1)  ·  Louise Badoux, MD (1)  ·  Moncef Feki, Professor (1)  ·  Neill Adhikari, MDCM FRCPC MSc (1)  ·  Osama Abou Arab, MD (1)

Results publications

PMID 31915072, PMID 34020705, PMID 35704292, PMID 39774855, PMID 40927646